Late relapse after autologous BMT
Salutari, P.; Micciulli, G.; Chiusolo, P.; Tommasi, M.; Di Mario, A.; Sica, S.; Leone, G.
Leukemia 10(5): 922-923
1996
ISSN/ISBN: 0887-6924 PMID: 8656692 Document Number: 459466
Document emailed within 1 workday
Related Documents
Schmid, H.; von Schenck, U.; Hartmann, R.; Borgmann, A.; Henze, G. 1996: Allogeneic BMT vs. chemotherapy in late bone marrow relapsed childhood non-T/non-B ALL: results of BFM ALL relapse studies. BFM Relapse Study Group Bone Marrow Transplantation 18(Suppl 2): 28-30Tricot, G.; Jagannath, S.; Vesole, D.H.; Crowley, J.; Barlogie, B. 1995: Relapse of multiple myeloma after autologous transplantation: survival after salvage therapy Bone Marrow Transplantation 16(1): 7-11
Erkus, M.; Bolaman, Z.; Meteoglu, I.; Kadikoylu, G. 2005: Localized extramedullary relapse after autologous hematopoietic stem cell transplantation in multiple myeloma Saudi Medical Journal 26(6): 989-991
Pavletic, S.Z.; Klassen, L.W.; Pope, R.; O'Dell, J.R.; Traynor, A.E.; Haire, C.E.; Graziano, F.; Oyama, Y.; Barr, W.; Burt, R.K. 2001: Treatment of relapse after autologous blood stem cell transplantation for severe rheumatoid arthritis Journal of Rheumatology. Supplement 64: 28-31
Schroeder, H.; Pinkerton, C.R.; Powles, R.L.; Meller, S.T.; Tait, D.; Milan, S.; Mcelwain, T.J. 1991: High dose melphalan and total body irradiation with autologous marrow rescue in childhood acute lymphoblastic leukaemia after relapse Bone Marrow Transplantation 7(1): 11-15
Soiffer, R.J.; Roy, D.C.; Gonin, R.; Murray, C.; Anderson, K.C.; Freedman, A.S.; Rabinowe, S.N.; Robertson, M.J.; Spector, N.; Pesek, K. 1993: Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse Bone Marrow Transplantation 12(3): 243-251
Alegre, Aán.; Granda, Aón.; Martínez-Chamorro, C.; Díaz-Mediavilla, Jín.; Martínez, R.; García-Laraña, Jé.; Lahuerta, J-José.; Sureda, A.; Bladé, J.; de la Rubia, J.; Fernández-Rañada, Jé.Maria.; San Miguel, Jús. 2002: Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry Haematologica 87(6): 609-614
Tkachenko, R.; Golovko, A.; Kuryk, O. 2018: A case report of late local relapse of adrenocortical carcinoma 18 years after adrenalectomy Experimental Oncology 40(3): 251-253
Van den Brande, J.; Schrijvers, D.; Vroman, P.; Prove, A.; Van Schil, P.; Becquart, D.; Van Marck, E.; Van Oosterom, A.T. 1998: Late relapse of a non-seminomatous germ cell tumour from residual mature teratoma Acta Clinica Belgica 53(3): 193-197
2014: Safety and efficacy of brentuximab vedotin (SGN-35) in Hodgkin lymphoma patients undergoing reduced intensity allogeneic stem cell transplant following a relapse after autologous transplant Clinical Advances in Hematology and Oncology: H&o 12(8 Suppl. 16): 20
Gloor, M.; Friederich, H.C. 1970: Late studies on the blood flow in free autologous whole skin autografts in man Dermatologische Monatschrift 156(4): 236-242
Richard, C.; Baro, J.; Bello-Fernandez, C.; Hermida, G.; Calavia, J.; Olalla, I.; Alsar, M.J.; Loyola, I.; Cuadrado, M.A.; Iriondo, A. 1995: Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) administration after autologous bone marrow transplantation for acute myeloblastic leukemia enhances activated killer cell function and may diminish leukemic relapse Bone Marrow Transplantation 15(5): 721-726
Dienstbier, Z.; Hermanská, Z.; Zámecník, J.; Melínová, L.; Vacková, B.; Skala, E.; Srbová, D. 1995: Relapse in Hodgkin's disease. Incidence of relapse in a group of 374 patients from 1 June 1968 to 31 March 1995 Vnitrni Lekarstvi 41(12): 816-821
Miggiano, M.C.; Gherlinzoni, F.; Rosti, G.; Bandini, G.; Visani, G.; Fiacchini, M.; Ricci, P.; Testoni, N.; Motta, M.R.; Geromin, A.; Rizzi, S.; Belardinelli, A.; Mangianti, S.; Manfroi, S.; Tura, S. 1996: Autologous bone marrow transplantation in late first complete remission improves outcome in acute myelogenous leukemia Leukemia 10(3): 402-409
Hernández, M.D.; del Cañizo, M.C.; González, M.; Caballero, M.D.; López-Berges, M.C.; Vázquez, L.; Orfao, A.; Corral, M.; Nieto, M.J.; San Miguel, J.F. 1998: Immune reconstitution after autologous progenitor hemopoietic cell transplantation. a study comparing autologous bone marrow and autologous peripheral blood transplantation Medicina Clinica 110(20): 768-773
Yamada, K.; Kawasumi, Y.; Yasuda, A.; Seki, Y.; Adachi, T.; Tarumi, O.; Hayashi, Y.; Nakagawa, T.; Yamada, N.; Ogawa, K. 2016: Changes in Mac Antibody Levels before and after Surgery and at the time of Relapse/Recurrence in Mac Lung Disease--Can Mac Antibodies be an Indicator of Postoperative Relapse/Recurrence? Kekkaku: 91(2): 41-44
Lopez, M.; Mortel, O.; Pouillart, P.; Zucker, J.M.; Fechtenbaum, J.; Douay, L.; Palangie, T.; Michon, J.; Salmon, D. 1990: Infusion of autologous peripheral blood nucleated cells hastens hematological recovery after high dose chemotherapy and autologous transplantation of bone marrow Bone Marrow Transplantation 5 Suppl. 1: 44-45
Bacenková, D.; Rosocha, J.; Svihla, R.; Vasko, G.; Bodnár, J. 2001: Repair of chondral defects of the knee using a combination of autologous chondrocytes and osteochondral allograft--an animal model. Part I: in vitro culture of autologous chondrocytes Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 68(6): 363-368
Hoover, H.C.; Surdyke, M.; Dangel, R.B.; Peters, L.C.; Hanna, M.G. 1984: Delayed cutaneous hypersensitivity to autologous tumor cells in colorectal cancer patients immunized with an autologous tumor cell: Bacillus Calmette-Guérin vaccine Cancer Research 44(4): 1671-1676
Fegan, C.; Thomas, H.; Bailey-Wood, R.; Coleman, S.; Phillips, S.; Hoy, T.; Whittaker, J.A. 1995: In vitro LAK (lymphokine activated killer) activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantation Bone Marrow Transplantation 16(2): 277-281